SCHEMBL30142924

SCHEMBL30142924

CC(=O)Nc1ccccc1C(=O)Nc1nc(-c2ccccc2)cs1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.67
KMT2A Q03164 7/20 0.67
RAB9A P51151 3/20 0.67
NPC1 O15118 2/20 0.67
MAPT P10636 5/20 0.62
ALDH1A1 P00352 4/20 0.62
KDM4E B2RXH2 3/20 0.62
HTT P42858 3/20 0.62
LMNA P02545 2/20 0.62
SMN1; SMN2 Q16637 2/20 0.62
POLB P06746 1/20 0.62
HSP90AA1 P07900 1/20 0.62
THRB P10828 1/20 0.62
HPGD P15428 1/20 0.62
BLM P54132 1/20 0.62
NPSR1 Q6W5P4 1/20 0.62
SAE1 Q9UBE0 1/20 0.62
UBA2 Q9UBT2 1/20 0.62
GAA P10253 2/20 0.61
MAPK1 P28482 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24074023 1.00 MEN1 (0.67) MEN1KMT2ARAB9ANPC1MAPT
SCHEMBL31134857 0.86 KMT2A (0.63) MEN1KMT2ARAB9ANPC1MAPT
SCHEMBL2020280 0.85 ABL1 (0.73) MEN1KMT2ARAB9ANPC1MAPT
SCHEMBL31134944 0.84 RAB9A (0.67) MEN1KMT2ARAB9ANPC1MAPT
SCHEMBL2754054 0.83 KDM4E (0.80) MEN1KMT2ARAB9ANPC1MAPT
SCHEMBL31665141 0.83 KDM4E (0.80) MEN1KMT2ARAB9ANPC1MAPT
SCHEMBL27134394 0.83 NPC1 (0.69) MEN1KMT2ARAB9ANPC1MAPT
SCHEMBL2753865 0.83 MEN1 (0.80) MEN1KMT2ARAB9ANPC1MAPT
SCHEMBL7236472 0.83 RAB9A (0.77) MEN1KMT2ARAB9ANPC1MAPT
SCHEMBL24074120 0.82 NPC1 (0.50) MEN1KMT2ARAB9ANPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 US disclosed
CN-116472292-A Modified proteins and protein degrading agents 上海睿跃生物科技有限公司 2023-07-21 CN disclosed
EP-4157888-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS Cullgen (Shanghai), Inc. (CN) 2023-04-05 EP disclosed
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2023-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 MEN1 3254/4885KMT2A 1342/4885RAB9A 3280/4885
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 MEN1 3254/4885KMT2A 1342/4885RAB9A 3280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.